Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance

Abstract excerpt

Sir, We read with interest the correspondence regarding the use of clindamycin in the treatment of patients with infections caused by erythromycin-resistant staphylococci, expressing inducible clindamycin resistance (ICR).1,2 We have been unsure as to the clinical significance of ICR in the treatment of patients with infection due to these organisms. We have recently treated three such patients with clindamycin;...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antifungal resistance and susceptibility
• Share to Antimicrobial Resistance in Staphylococcus
• Share to Microbial Metabolism and Applications